| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Martin Demora Hale last filed a Form 4 in February 2016, as Director at IOSP. Martin Demora Hale's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 181,480 shares of IOSP. The IOSP filings lean toward selling, a net 10,000 shares.
Martin Demora Hale has 6 Form 4 filings on record from January 2015 to February 2016, all as Director at Innospec (IOSP), 2015–2016.
The 10 reported transactions were 4 option or other derivative awards, 3 open-market sales, 2 option exercises and 1 gift.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $571K.
The only open-market sale was 10,000 shares of IOSP at an average $57.13 on December 4, 2015, about $571K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2015 | IOSP Innospec Inc. | Director | Sell | 10,000 | $57.13 | $571,283.00 | -5.2% |